Citizens Business Bank Has $4.65 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Citizens Business Bank reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,835 shares of the healthcare conglomerate’s stock after selling 316 shares during the period. UnitedHealth Group comprises 1.0% of Citizens Business Bank’s investment portfolio, making the stock its 29th largest holding. Citizens Business Bank’s holdings in UnitedHealth Group were worth $4,651,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Wellington Management Group LLP grew its stake in shares of UnitedHealth Group by 2.1% in the third quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after purchasing an additional 527,526 shares during the last quarter. Northern Trust Corp increased its stake in shares of UnitedHealth Group by 3.6% in the third quarter. Northern Trust Corp now owns 9,787,768 shares of the healthcare conglomerate’s stock valued at $4,934,895,000 after buying an additional 341,749 shares during the period. Bank of New York Mellon Corp lifted its stake in shares of UnitedHealth Group by 2.2% in the third quarter. Bank of New York Mellon Corp now owns 8,242,282 shares of the healthcare conglomerate’s stock worth $4,155,676,000 after acquiring an additional 180,331 shares during the period. Charles Schwab Investment Management Inc. increased its position in UnitedHealth Group by 0.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 5,843,207 shares of the healthcare conglomerate’s stock valued at $2,937,976,000 after purchasing an additional 27,127 shares during the period. Finally, Sanders Capital LLC lifted its position in shares of UnitedHealth Group by 6.5% in the 3rd quarter. Sanders Capital LLC now owns 5,757,410 shares of the healthcare conglomerate’s stock worth $2,902,829,000 after purchasing an additional 352,710 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

NYSE:UNH traded down $5.33 during trading hours on Tuesday, hitting $483.70. The stock had a trading volume of 3,366,904 shares, compared to its average volume of 4,466,545. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The company has a 50 day simple moving average of $485.19 and a two-hundred day simple moving average of $513.81. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The firm has a market capitalization of $445.04 billion, a price-to-earnings ratio of 29.63, a P/E/G ratio of 1.43 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. During the same quarter in the previous year, the firm earned $6.26 earnings per share. UnitedHealth Group’s revenue was up 8.6% on a year-over-year basis. Research analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.55%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 45.97%.

Analyst Upgrades and Downgrades

UNH has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft boosted their target price on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a report on Friday, April 19th. Barclays upped their target price on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Piper Sandler boosted their price target on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Wells Fargo & Company decreased their target price on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research report on Monday, April 8th. Finally, Morgan Stanley lowered their target price on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a report on Friday, April 5th. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $570.05.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.